PPARG and lipodystrophy: Although we found small scale evidence supporting greater A1c reduction with TZDs in PPARG vs. LMNA-related lipodystrophy, only 5 patients with PPARG-related lipodystrophy in whom TZD effects were clearly described were reported, and responses were inconsistent.